Citadel Advisors’s Fractyl Health GUTS Stock Holding History

Citadel Advisors’s Portfolio GUTS Stock Details GUTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22.1K	Sell	48,196 -180,789	-79%	-$167K	﹤0.01%	12650
2025 Q4	$504K	Sell	228,985 -1,553,371	-87%	-$2.5M	﹤0.01%	9000
2025 Q3	$2.83M	Buy	+1,782,356	New	+$2.31M	﹤0.01%	5404
2025 Q2	–	Sell	-100,345	Closed	-$119K	–	15473
2025 Q1	$119K	Sell	100,345 -631,664	-86%	-$1.01M	﹤0.01%	11211
2024 Q4	$1.51M	Sell	732,009 -90,821	-11%	-$211K	﹤0.01%	6211
2024 Q3	$2.08M	Buy	822,830 +32,573	+4%	+$106K	﹤0.01%	5455
2024 Q2	$3.37M	Sell	790,257 -913,579	-54%	-$5.88M	﹤0.01%	4374
2024 Q1	$12.6M	Buy	+1,703,836	New	+$14.3M	﹤0.01%	2623

Other funds holding GUTS

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCM

Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

DMC

Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors's GUTS Position: Q1 2026 in Review

Citadel Advisors reduced its Fractyl Health (GUTS) stake by 79% in Q1 2026, selling an estimated $167K and leaving 48,196 shares worth $22.1K. The position accounts for ﹤0.01% of the portfolio, ranked #12650.

Citadel Advisors first reported a position in GUTS in Q1 2024 and has held it in 8 quarters since. The position peaked at $12.6M in Q1 2024. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

Citadel Advisors held 48,196 shares of Fractyl Health worth $22.1K as of Q1 2026.
Citadel Advisors sold 180,789 Fractyl Health shares in Q1 2026, an estimated $167K.
Fractyl Health made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12650 holding.
Citadel Advisors first reported a position in Fractyl Health in Q1 2024 and has held it in 8 quarters since.
Citadel Advisors's Fractyl Health position peaked at $12.6M in Q1 2024.
83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.